In this episode, Graham R. Foster, FRCP, PhD, and Paul Y. Kwo, MD, share lessons learned in the management of HCC and liver transplantation the COVID-19 era, including:• Global impact of HCC and strategies for maintaining HCC care in the COVID-19 era• Characteristics of liver transplant recipients in the COVID-19 era• Impact of COVID-19 pandemic period on liver transplant outcomes• Impact of liver transplant status on COVID-19 outcomes• Strategies for providing streamlined care for patients with liver cancer or liver transplantation in the COVID-19 eraPresenters:Graham R. Foster, FRCP, PhD Professor of Hepatology The Liver UnitConsultant Hepatologist Queen Mary University of LondonLondon, United KingdomPaul Y. Kwo, MDProfessor of Medicine Director of HepatologyStanford University School of MedicinePalo Alto, CaliforniaFollow along with the slides at:https://bit.ly/3HQ6dZ5Link to full program: https://bit.ly/3Bgyd5I Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related